Lu AF28996 / Lundbeck - LARVOL DELTA

Lu AF28996 in Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=57 | Active, not recruiting | Sponsor: H. Lundbeck A/S | Recruiting ➔ Active, not recruiting

Enrollment closed • CNS Disorders • Movement Disorders • Parkinson's Disease

Lu AF28996 in Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=63 | Recruiting | Sponsor: H. Lundbeck A/S | Trial completion date: Jul 2025 ➔ Feb 2026 | Trial primary completion date: Jul 2025 ➔ Oct 2025

Trial completion date • Trial primary completion date • CNS Disorders • Movement Disorders • Parkinson's Disease

A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men (clinicaltrials.gov) - P1 | N=8 | Completed | Sponsor: H. Lundbeck A/S | Recruiting ➔ Completed

Trial completion

A Trial Investigating Lu AF28996 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=22 | Completed | Sponsor: H. Lundbeck A/S | Active, not recruiting ➔ Completed

Trial completion

A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men (clinicaltrials.gov) - P1 | N=8 | Recruiting | Sponsor: H. Lundbeck A/S | Not yet recruiting ➔ Recruiting

Enrollment open

A Trial Investigating Lu AF28996 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=22 | Active, not recruiting | Sponsor: H. Lundbeck A/S | Recruiting ➔ Active, not recruiting

Enrollment closed

A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men (clinicaltrials.gov) - P1 | N=8 | Not yet recruiting | Sponsor: H. Lundbeck A/S

New P1 trial

A Trial Investigating Lu AF28996 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: H. Lundbeck A/S | Not yet recruiting ➔ Recruiting

Enrollment open

A Trial Investigating Lu AF28996 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=24 | Not yet recruiting | Sponsor: H. Lundbeck A/S

New P1 trial

Lu AF28996 in Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=77 | Recruiting | Sponsor: H. Lundbeck A/S | N=29 ➔ 77 | Trial completion date: Oct 2023 ➔ Jul 2025 | Trial primary completion date: Oct 2023 ➔ Jul 2025

Enrollment change • Trial completion date • Trial primary completion date • CNS Disorders • Movement Disorders • Parkinson's Disease

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=6 | Completed | Sponsor: H. Lundbeck A/S | Active, not recruiting ➔ Completed

Trial completion • CNS Disorders • Movement Disorders • Parkinson's Disease

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=6 | Active, not recruiting | Sponsor: H. Lundbeck A/S | Recruiting ➔ Active, not recruiting

Enrollment closed • CNS Disorders • Movement Disorders • Parkinson's Disease

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=6 | Recruiting | Sponsor: H. Lundbeck A/S | Not yet recruiting ➔ Recruiting

Enrollment open • CNS Disorders • Movement Disorders • Parkinson's Disease

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=6 | Not yet recruiting | Sponsor: H. Lundbeck A/S

New P1 trial • CNS Disorders • Movement Disorders • Parkinson's Disease

Lu AF28996 in Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1 | N=37 | Recruiting | Sponsor: H. Lundbeck A/S | N=17 ➔ 37 | Trial completion date: Sep 2022 ➔ Aug 2023 | Trial primary completion date: Sep 2022 ➔ Aug 2023

Enrollment change • Trial completion date • Trial primary completion date • CNS Disorders • Movement Disorders • Parkinson's Disease

Lu AF28996 in Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1; N=17; Recruiting; Sponsor: H. Lundbeck A/S; Trial primary completion date: Dec 2021 ➔ Sep 2022

Clinical • Trial primary completion date • CNS Disorders • Movement Disorders • Parkinson's Disease

Lu AF28996 in Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1; N=17; Recruiting; Sponsor: H. Lundbeck A/S; Trial completion date: Dec 2021 ➔ Jul 2022

Clinical • Trial completion date • CNS Disorders • Movement Disorders • Parkinson's Disease

Lu AF28996 in Participants With Parkinson's Disease (PD) (clinicaltrials.gov) - P1; N=17; Recruiting; Sponsor: H. Lundbeck A/S; N=10 ➔ 17

Clinical • Enrollment change • CNS Disorders • Movement Disorders • Parkinson's Disease

Lu AF28996 in Patients With Parkinson's Disease (PD) (clinicaltrials.gov) - P1; N=10; Recruiting; Sponsor: H. Lundbeck A/S; Trial completion date: Dec 2020 ➔ Dec 2021; Trial primary completion date: Dec 2020 ➔ Dec 2021

Clinical • Trial completion date • Trial primary completion date • CNS Disorders • Movement Disorders • Parkinson's Disease

Lu AF28996 in Patients With Parkinson's Disease (PD) (clinicaltrials.gov) - P1; N=10; Recruiting; Sponsor: H. Lundbeck A/S

Clinical • New P1 trial

Single Dose of Lu AF28996 to Healthy Young Men (clinicaltrials.gov) - P1; N=39; Completed; Sponsor: H. Lundbeck A/S; Recruiting ➔ Completed; N=18 ➔ 39; Trial completion date: Mar 2019 ➔ Aug 2019; Trial primary completion date: Mar 2019 ➔ Aug 2019

Clinical • Enrollment change • Trial completion • Trial completion date • Trial primary completion date